Member access

4-Traders Homepage  >  Shares  >  Oslo Bors  >  Algeta ASA       NO0010239437

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Latest news on ALGETA ASA
05/16 ALGETA ASA: New data and analyses from clinical trials of Xofigo® (radium-223 d..
05/15 ALGETA ASA: Algeta announces that Xofigo® (radium-223 dichloride) has been appr..
05/15 ALGETA ASA: Algeta results for the first quarter 2013
05/14 ALGETA ASA: Algeta to Participate in Upcoming Investor Conferences
05/07 ALGETA ASA: Algeta schedules first quarter 2013 results presentation, webcast a..
05/02 ALGETA ASA: Algeta exercises option and signs exclusive license agreement with ..
04/17 ALGETA ASA: Algeta to Participate in Upcoming Investor Conference
03/20 ALGETA ASA: Algeta - Notice of Annual General Meeting 2013
02/25ALGETA ASA: quaterly earnings release
02/20 ALGETA ASA: Algeta to Participate in Upcoming Investor Conferences
01/28 ALGETA ASA: Algeta initiates new oncology research program to evaluate the pote..
2012 ALGETA ASA: Algeta's partner Bayer submits New Drug Application to US FDA for R..
2012 ALGETA ASA: Algeta's partner Bayer submits Radium-223 Dichloride for EU Marketi..
2012 ALGETA ASA: Algeta to Present at Upcoming Investor Conferences
2012 ALGETA ASA: Algeta and Ablynx enter into a research collaboration to evaluate t..
2012 ALGETA ASA: Algeta results for the third quarter 2012
2012ALGETA ASA: quaterly earnings release
2012 ALGETA ASA: Algeta to Participate in Upcoming Investor Conferences
2012 ALGETA ASA: Algeta US Celebrates Official Opening of Operational Center in Camb..
2012 ALGETA ASA: Algeta to Participate in Upcoming Investor Conferences
2012 ALGETA ASA: Algeta initiates new R&D program to investigate a Targeted Thorium ..
2012 ALGETA ASA: Algeta results for the first half and second quarter 2012
2012 ALGETA ASA: Algeta to Present at Forthcoming Life Sciences Investor Conferences
2012 ALGETA ASA: Algeta reports results for the first quarter 2012
2012 ALGETA ASA: Algeta and Sanofi extend research collaboration evaluating thorium-..
2012 ALGETA ASA: Algeta schedules first quarter 2012 results presentation, webcast a..
2012 ALGETA ASA: Algeta exercises option to co-promote Alpharadin in the United Stat..
2012 ALGETA ASA: Algeta to Present at Forthcoming Life Sciences Investor Conferences
2012 ALGETA ASA: Algeta to Present at Forthcoming Life Sciences Investor Conferences
2012 ALGETA ASA: Algeta results for the fourth quarter 2011 and full year 2011
2012DJALGETA ASA: WSJ BLOG/Health : A.M. Vitals: Prostate-Cancer Drugs Improve Surviv..
2012 ALGETA ASA: Algeta schedules fourth quarter 2011 results presentation, webcast ..
2012 ALGETA ASA: Algeta President & CEO Andrew Kay to present at the 30th Annual J.P..
2011 ALGETA ASA: Positive phase IIa bone marker data of Alpharadin in breast cancer ..
2011 ALGETA ASA: Algeta results for the third quarter 2011
2011 ALGETA ASA: Algeta's Financial Calendar 2012
2011 ALGETA ASA: Algeta schedules third quarter 2011 results presentation, webcast a..
2011 ALGETA ASA: Algeta to Host Investor Meeting, Webcast and Conference Call to Dis..
2011 ALGETA ASA: Alpharadin Significantly Improves Overall Survival for Patients wit..
2011 ALGETA ASA: Algeta to Present at Forthcoming Life Sciences Investor Conferences
2011 ALGETA ASA: Alpharadin Phase III Trial Data to be presented at Best and Late-Br..
2011 ALGETA ASA: Algeta appoints Mike Booth as Senior Vice President, Communications..
2011 ALGETA ASA: FDA Grants Fast Track Designation to Alpharadin for the Treatment o..
2011 ALGETA ASA: Algeta results for the first half and second quarter 2011
2011 ALGETA AS: Algeta schedules second quarter 2011 results presentation, webcast a..
2011 ALGETA AS: Algeta awarded grant to develop new tumor-targeted alpha-pharmaceuti..
2011 ALGETA AS: Algeta announces positive preliminary bone marker results in a phase..
2011 ALGETA AS: Gjennombrudd for Algeta
2011 ALGETA AS: Positive Outcome of Interim Analysis of pivotal Alpharadin study: Pr..
2011 ALGETA AS: Clinical analysis of Alpharadin to be presented at the 2011 Annual M..
2010 ALGETA ASA: Nanostart-Held Lumiphore Announces Cooperation Agreement with Leadi..
2010 ALGETA ASA: to present at forthcoming life sciences investor conferences
2010 ALGETA ASA: financial calendar 2011
2010 ALGETA ASA: results for the second quarter and first half 2010
2010 ALGETA ASA: announces first cancer patient treated in phase I/IIa trial of Alph..
2010 ALGETA ASA: schedules second quarter 2010 results presentation and webcast
2010 ALGETA ASA: concludes agreements for the manufacture and supply of Alpharadin f..
2010 ALGETA ASA: to present at two upcoming life sciences
2010 ALGETA ASA: hosts Capital Markets Day in Oslo
2010 ALGETA ASA: Results for the First Quarter 2010
2010 ALGETA ASA: schedules First Quarter 2010 Presentation
2010 ALGETA ASA: completes successful sample size re-estimation of pivotal ALSYMPCA ..
2010 ALGETA ASA: Leading medical experts in bone metastases and prostate cancer ther..
2010 ALGETA ASA: elects US experienced pharma industry executives Judith Hemberger a..
2010 ALGETA ASA: Annual general meeting held in Algeta
2010 ALGETA ASA: kåret til årets nyskaper
2010 ALGETA ASA: - Notice of Annual General Meeting 2010
2010 ALGETA ASA: New clinical analyses from Alpharadin clinical programs to be prese..
2010 ALGETA ASA: to present at Cowen's 30th Annual Health Care Conference
2010 ALGETA ASA: Save the Dates: Algeta to host Capital Markets Days in Oslo (25 May..
2010 ALGETA ASA: Results for the Fourth Quarter and Full Year 2009
2010 ALGETA ASA: schedules Fourth Quarter 2009 Presentation
2010 ALGETA ASA: announces first patient treated in phase II trial of Alpharadin to ..
2010 ALGETA ASA: financial calendar 2010
1  2Next
Advertisement
Chart
Duration : Period :
Algeta ASA Technical Analysis Chart | NO0010239437 | 4-Traders
Income Statement Evolution
Algeta ASA : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.